logo

IPO

IPO
Gainers & Losers

IPO Synopsis

Senores Pharmaceuticals Ltd
Initial public offering of up to [*] equity shares of face value of Rs. 10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Offer Price") aggregating up to Rs. [*] crores (the "Offer"). The offer comprises of a fresh issue of upto [*] equity shares by the company aggregating upto Rs. 500.00 crores (the "Fresh Issue") and an offer for sale of up to 2,100,000 equity shares (the "Offered Shares") aggregating up to Rs. [*] crores (the "Offer for Sale"), comprising up to 250,000 equity shares aggregating to Rs. [*] crores by Swapnil Jatinbhai Shah, up to 550,000 equity shares aggregating to Rs. [*] crores by Ashokkumar Vijaysinh Barot, up to 300,000 equity shares aggregating to Rs. [*] crores by Sangeeta Mukur Barot and up to 1,000,000 equity shares aggregating to Rs. [*] crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of up to 75,000 equity shares, aggregating up to Rs. [*] crores (constituting [*] of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". Price Band: Rs. 372 to Rs. 391 per equity share of face value of Rs. 10 each. The Floor price is 37.20 times the face value of the equity shares and cap price is 39.10 times the face value of the equity shares. Bid can be made for a minimum of 38 equity shares and in multiples of 38 equity shares.
Issue
Opens On Closes On
20-Dec-24 24-Dec-24
Money Payable On
Application Allotment
372.00 0.00
Minimum Application for shares in Nos : 38 Further Multiples of : 38
Cr Lead Managers to the Issue
Project Cost (.Cr) 0.00 Ambit Pvt Ltd
Project Financed through Current Offer (.Cr) 578.12  
Post Issue Equity Share Capital (.Cr) 46.05
Issue Price () 372.00
Projects
Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta Facility
Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSI
Funding the working capital requirements of the company and its subsidiary namely SPI ad Ratnatris
Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes
Investment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries
Investment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements
Promoted By
Swapnil Jatinbhai
Ashokkumar Vijaysingh Barot
Anar Swapnil Shah
Listing At
BSE
NSE
Registrar to the Issue
Link Intime India Pvt Ltd